Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database.

Matsumoto, Kiyoka; Nakao, Satoshi; Hasegawa, Shiori; Matsui, Toshinobu; Shimada, Kazuyo; Mukai, Ririka; Tanaka, Mizuki; Uranishi, Hiroaki; Nakamura, Mitsuhiro

Matsumoto, Kiyoka; Nakao, Satoshi; Hasegawa, Shiori; Matsui, Toshinobu; Shimada, Kazuyo; Mukai, Ririka; Tanaka, Mizuki; Uranishi, Hiroaki; Nakamura, Mitsuhiro.

Afiliación

Matsumoto K; Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.
Nakao S; Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.
Hasegawa S; Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.
Matsui T; Department of Pharmacy, Kobe City Medical Center General Hospital, Kobe, Japan.
Shimada K; Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.
Mukai R; Department of Pharmacy, Gifu Prefectural Tajimi Hospital, Tajimi, Japan.
Tanaka M; Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.
Uranishi H; Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.
Nakamura M; Laboratory of Drug Informatics, Gifu Pharmaceutical University, Gifu, Japan.

SAGE Open Med ; 8: 2050312120918264, 2020.

Article en En | MEDLINE | ID: mdl-32528682

Palabras clave

Drug-induced interstitial lung disease; pharmacovigilance; the Japanese Adverse Drug Event Report database; time-to-onset profile

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: SAGE Open Med Año: 2020 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google